Beijing Tightens the Screws on Offshore IPOs, Casting a Shadow Over Tech and Biotech Ambitions
The move signals a strategic pivot from unfettered capital access to controlled growth, prioritizing regulatory oversight and national interest in sensitive sectors. Chinese regulators are…